RxSight, Inc. (RXST)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about RxSight, Inc. (RXST)
Company Performance

Current Price

as of Oct 16, 2024

$50.66

P/E Ratio

N/A

Market Cap

$2.01B

Description

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Metrics

Overview

  • HQAliso Viejo, CA
  • SectorElectronic Technology
  • IndustryElectronic Components
  • TickerRXST
  • Price$50.66+2.12%

Trading Information

  • Market Cap$2.01B
  • Float94.89%
  • Average Daily Volume (1m)412,359
  • Average Daily Volume (3m)494,667
  • EPS-$1.01

Company

  • Revenue$115.18M
  • Rev Growth (1yr)67.65%
  • Net Income-$6.08M
  • Gross Margin69.51%
  • EBITDA Margin-21.54%
  • EBITDA-$7.51M
  • EV$2.09B
  • EV/Revenue18.16
  • P/EN/A
  • P/S16.91
  • P/B7.29
Documents